(Total Views: 468)
Posted On: 05/15/2025 12:32:18 PM
Post# of 156317
Also don’t forgot about ESMO this summer.
https://delta.larvol.com/NewsItem/NewsItemID/...tal+Cancer.
134eP - Observed Survival Following Treatment With Leronlimab In Patients With Metastatic Colorectal Cancer.
Session Name
Poster display session and coffee break
Room
Foyer
Date
Fri, 04.07.2025
Lecture Time
15:30 - 15:30
Speakers
Ari Baron (San Francisco, United States of America)
https://delta.larvol.com/NewsItem/NewsItemID/...tal+Cancer.
134eP - Observed Survival Following Treatment With Leronlimab In Patients With Metastatic Colorectal Cancer.
Session Name
Poster display session and coffee break
Room
Foyer
Date
Fri, 04.07.2025
Lecture Time
15:30 - 15:30
Speakers
Ari Baron (San Francisco, United States of America)
(2)
(0)
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
